Dubai: The Centre for Advanced Biomedical Research and Innovation (CABRI) at the Gulf Medical University in Ajman has received accreditation from the College of American Pathologists (CAP).
The much coveted credential positions CABRI as a high quality speciality pathology laboratory.
This makes it possible for the community in the northern emirates to avail of the high-quality speciality test services offered by CABRI.
“This is a great achievement by a relatively young research centre and I am proud of this feat,” said Thumbay Moideen, Founder President, Board of Governors, Gulf Medical University.
The Thumbay Foundation has announced a grant of Dh10 million over the next six years to encourage researchers to conduct medical research and innovation of the highest scientific calibre.
To facilitate this, Moideen has also announced the establishment of a state-of-the-art Innovation Centre under the aegis of CABRI to facilitate medical research and innovation.
“This achievement has opened the doors for transition of our institution from a purely academic institution to that of a research and innovation- based university,” said Prof Gita Ashok Raj, Provost of Gulf Medical University.
Professor P.K. Menon, Director, CABRI, added that CABRI envisages inter-institutional collaborations and public-private partnerships to enhance its research scope in the near future. He also said that among the new tests launched, neonatal screening using a blood spot on card has been launched at CABRI to provide assistance in screening infants for 54 treatable conditions.
The Centre for Advanced Biomedical Research and Innovation, set-up at Gulf Medical University Ajman, focuses on research studies and advanced diagnostics in nationally important health areas such as diabetes, cardiovascular diseases, genetic disorders, allergies and thalassaemia.
CABRI is already working with some of the multinational companies on different research projects, and aims to focus on diagnostic testing. The centre has, in addition, the ability to do bio-analytical testing, toxicology testing and rare metal analysis. The centre aims to be a leading service provider for high complexity testing in the next three-five years.
